New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy

Home > Science Hub > New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
Back to the list

April 11, 2024

You might also be interested by

Webcasts & Webinars

Let's Talk: A Conversation with Dr. Thomas Powles

December 19, 2024

More info

News

Let's Talk: A Conversation with Dr. Thomas Powles

November 28, 2024

More info

Posters

Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

November 19, 2024

More info

Posters

Accelerating analysis of cytometry data sets leveraging a visualization tool built within CellEngine, a cloud-based cytometry analysis software

November 7, 2024

More info